Beta-Lactam Antibiotics as A Possible Novel Therapy for Managing Epilepsy and Autism, A Case Report and Review of Literature

GHANIZADEH*, Ahmed and BERK, Michael (2015) Beta-Lactam Antibiotics as A Possible Novel Therapy for Managing Epilepsy and Autism, A Case Report and Review of Literature. Iranian Journal of Child Neurology, 9 (1). pp. 99-102.

[thumbnail of 5493-Article Text (Word file)-28902-2-10-20150122.pdf] Text
5493-Article Text (Word file)-28902-2-10-20150122.pdf - Published Version

Download (288kB)

Abstract

Autism is a disorder of unknown etiology. There are few FDA approved medications for treating autism. Co-occurring autism and epilepsy is common, and glutamate antagonists improve some symptoms of autism. Ceftriaxone, a beta-lactam antibiotic, increases the expression of the glutamate transporter 1 which decreases extracellular glutamate levels. It is hypothesized that modulating astrocyte glutamate transporter expression by ceftriaxone or cefixime might improve some symptoms of autism. This case report of a child with autism and epilepsy suggests a decrease in seizures after taking cefixime.

Item Type: Article
Subjects: Academic Digital Library > Medical Science
Depositing User: Unnamed user with email info@academicdigitallibrary.org
Date Deposited: 10 Mar 2023 07:13
Last Modified: 04 Jun 2024 10:52
URI: http://publications.article4sub.com/id/eprint/897

Actions (login required)

View Item
View Item